[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RayzeBio is being acquired by Bristol Myers Squibb for $XXXXX per share. Social media engagement is high, reflecting positive sentiment around the acquisition news.
RayzeBio, Inc. Common Stock (RYZB) is a stock in the healthcare sector.
RayzeBio, Inc. Common Stock uses the ticker $RYZB for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The price is currently at $62.50, which is the 1-year high and low, likely due to the acquisition news.
1-Year High: $XXXXX on 2024-10-16
1-Year Low: $XXXXX on 2024-10-16
AltRank 24-Hour Time-Series Raw Data
RayzeBio, Inc. Common Stock (RYZB) is currently AltRank #1,968 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX +65
1 Month: XXXXX +686
6 Months: XXXXX +52
1 Year: XXXXX +93
1-Year High: XXXXX on 2025-08-24
1-Year Low: XXX on 2025-04-05
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -X
1-Year High: XX on 2025-03-02
1-Year Low: XX on 2024-10-26
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXXXX +613%
1 Month: XXXXX -XX%
6 Months: XXXXXX +296%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-05-29
1-Year Low: X on 2024-10-21
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Week: X -XX%
1 Month: X -XX%
6 Months: XXX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2024-10-21
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning RayzeBio, Inc. Common Stock (RYZB) in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X -XX%
1 Month: X -XX%
6 Months: XX -XX%
1 Year: XXX -XX%
1-Year High: XX on 2024-10-22
1-Year Low: X on 2024-10-20
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXX% +0.00019999999999999993%
1 Month: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXXX% +0.00010000000000000005%
1 Year: XXXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXXX% on 2025-07-06
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-04-08
1-Year Low: XXXXXX% on 2025-10-06
Top assets mentioned In the posts about RayzeBio, Inc. Common Stock in the last XX hours
Bristol-Myers Squibb Co (BMY) Cytokinetics Inc. (CYTK) Karuna Therapeutics, Inc. Common Stock (KRTX) Tourmaline Bio, Inc. Common Stock (TRML) Akropolis (AKRO)
Top topics mentioned In the posts about RayzeBio, Inc. Common Stock in the last XX hours
stocks healthcare, $bmy, $cytk, $krtx, $myok, $6250sh, $41bn, $iinn, $arbb, $avtx, $trml, $akro, $stok
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5571 followers, 8202 engagements
"$avtx $trml $akro $stok $ryzb $xbi what do they all have in common. Aaron Kantoff"
X Link @badinvestor99 2025-10-10T12:43Z XXX followers, XXX engagements
"👀Todays watch: $RYZB doubled on Bristol Myers paying $XXX Billion $IINN announces XX% accuracy result for their blood sensor product Others: $ARBB $GRCL $SXTP $BACK Let's make this week legendary 🚀💸"
X Link @anyatrades 2023-12-26T14:22Z 233.7K followers, 82.9K engagements
"$RYZB RayzeBio to be acquired by Bristol Myers Squibb for $62.50/sh or $4.1bn $BMS"
X Link @EricTokat 2023-12-26T12:03Z 3551 followers, 50.6K engagements